Organisation
Clinical Emerging Infectious Diseases
Research Unit
Current researchers
1 - 2 of 2 results
- Elise De Vos (Member)
- Laurens Liesenborghs (Member)
Projects
1 - 2 of 2
- Improving the clinical management and facility-based surveillance of febrile illness in rural Guinea: a multidisciplinary approachFrom1 Jan 2023 → Today
- Determining the drivers behind Monkeypox virus transmission: a multidisciplinary ‘one health’ study of an emerging zoonotic pathogenFrom1 Jan 2022 → Today
Publications
1 - 10 of 32
- Urethritis without skin lesions as the primary manifestation of Mpox virus infection(2023)
Authors: Laurens Liesenborghs, Veerle Huyst, Christophe Van Dijck, Jojanneke Rutgers, Irith De Baetselier, Christopher Kenyon, M. Van Esbroeck, Koen O. A. Vercauteren
Pages: 378-379 - Characteristics of confirmed mpox cases among clinical suspects: a prospective single-centre study in Belgium during the 2022 outbreak(2023)
Authors: Matilde Hens, Isabel Brosius, Nicole Berens-Riha, Jasmine Coppens, Liesbeth Van Gestel, Jojanneke Rutgers, Christopher Kenyon, Patrick Soentjens, Saskia van Henten, Stefanie Bracke, et al.
Pages: 101093 - Detection of mpox virus in ambient air in a sexual health clinic(2023)
Authors: Joren Raymenants, Liesbeth Van Gestel, Jasmine Coppens, Tessa de Block, Ndim Eugene Bangwen, Jojanneke Rutgers, Matilde Hens, Elise De Vos, Sandra Coppens, Els Keyaerts, et al.
- Staphylococcus aureus, master manipulator of the human hemostatic system(2018)
Authors: Laurens Liesenborghs, Peter Verhamme, Thomas Vanassche
Pages: 441-454 - An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models(2021)
Authors: Bert Schepens, Loes van Schie, Wim Nerinckx, Kenny Roose, Wander Van Breedam, Daria Fijalkowska, Simon Devos, Wannes Weyts, Sieglinde De Cae, Sandrine Vanmarcke, et al.
- The human Mpox global outbreak: available control tools and the opportunity to break a cycle of neglect in endemic countries(2023)
Authors: Jean B Nachega, Placide Mbala-Kingebeni, Philip J Rosenthal, Anne W Rimoin, Nicole A Hoff, Laurens Liesenborghs, Veerle Vanlerberghe, Graciela Andrei, Angeli Rawat, Lindsay A Wilson, et al.
Pages: 719-724 - Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity(2020)
Authors: Suzanne J. F. Kaptein, Sofie Jacobs, Lana Langendries, Laura Seldeslachts, Sebastiaan ter Horst, Laurens Liesenborghs, Bart Hens, Valentijn Vergote, Elisabeth Heylen, Karine Barthelemy, et al.
Pages: 26955-26965 - Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra(2022)
Authors: Matthias M. Engelen, Quentin Van Thillo, Albrecht Betrains, Iwein Gyselinck, Caroline P Martens, Valérie Spalart, Anna Ockerman, Caroline Devooght, Joost Wauters, Jan Gunst, et al.
- Mpox screening in high-risk populations finds no asymptomatic cases(2022)
Authors: Christophe Van Dijck, Irith De Baetselier, Christopher Kenyon, Laurens Liesenborghs, Koen O. A. Vercauteren, M. Van Esbroeck
- Leveraging T-cell receptor - epitope recognition models to disentangle unique and cross-reactive T-cell response to SARS-CoV-2 during COVID-19 progression/resolution(2023)
Authors: Anna Postovskaya, Alexandra Vujkovic, Tessa de Block, Lida van Petersen, Maartje van Frankenhuijsen, Isabel Brosius, Emmanuel Bottieau, Christophe Van Dijck, Caroline Theunissen, Sabrina H van Ierssel, et al.